It's been nearly eighteen months since Governor Cuomo signed legislation to legalize medical marijuana, and with only a few weeks left before the Compassionate Care Act is due to take effect, the five companies licensed to grow and sell cannabis are rushing to meet the deadline.
Vireo Health of New York, one of the state's five medical-marijuana companies, announced today it has a new chief executive: Ari Hoffnung, a former deputy comptroller for the city and an applicant who just barely missed the cut for a state marijuana license in July.
Vireo Health announced today that Ari Hoffnung has been appointed as the new Chief Executive Officer of Vireo Health of New York. Hoffnung will lead the company, which has one manufacturing facility and four dispensaries throughout the state and will begin serving patients in January. He replaces Dr. Kyle Kingsley who will continue to serve as Chairman of the Board.
Minnesota Medical Solutions has named the strain "Katelyn Faith" in memory of Katelyn Faith Pauling, an 8-year-old girl from Montevideo, Minn. who died from complications of Battens Disease less than 4 months before Minnesota’s medical cannabis law took effect.
“This is a great example of how patients benefit from our focus on scientific research,” said Kyle Kingsley, M.D., Chief Executive Officer of Vireo Health. “This discovery will eventually lead to lower prices for many patients."